Streetbeat News

Stock Prices

SPY

U.S. futures are pricing in an 89% chance of a 25 basis points hike this month, up slightly from before the jobs data was released. However, the odds of a rate hike in November have been pared down to 39% post-jobs, compared to 45% just before the data was released.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:40 pm

AFRM

Affirm Holdings, Inc. (NASDAQ:AFRM) stock traded lower after Piper Sandler downgraded the stock from Neutral to Underweight. The options market indicates heavy volatility for Affirm in the coming weeks and months. Traders expect Affirm’s stock to not recover above the $15 level between now and August 18. Piper Sandler analyst Kevin J. Barker expects persistently higher rates to pressure operating margins as AFRM needs to hold more loans on the balance sheet.

Portfolio Pulse from Lisa Levin

July 07, 2023 | 12:39 pm

NUZE

NuZee has entered into a five-year global licensing agreement with Stone Brewing, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 12:36 pm

ZVSA

ZyVersa Therapeutics has been granted a patent by the European Patent Office for its Phase 2a-ready Cholesterol Efflux Mediator VAR 200, intended for use in diabetic nephropathy/diabetic kidney disease. This news has led to an increase in the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 12:35 pm

CAMP

IMOS

MEI

OSIS

RELL

The article lists five tech stocks that are currently oversold, presenting a potential buying opportunity. The companies mentioned are ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS), CalAmp Corp. (NASDAQ:CAMP), Methode Electronics, Inc. (NYSE:MEI), OSI Systems, Inc. (NASDAQ:OSIS), and Richardson Electronics, Ltd. (NASDAQ:RELL). The oversold status is determined by the Relative Strength Index (RSI), which is below 30 for all these stocks.

Portfolio Pulse from Lisa Levin

July 07, 2023 | 12:35 pm

BCLI

BrainStorm Cell Therapeutics Inc (NASDAQ:BCLI) presented new biomarker data from the Phase 3 trial of its ALS treatment, NurOwn, showing significant elevation in markers of neuroprotection and reduction in markers of neuroinflammation and neurodegeneration. Statistical modeling identified three biomarkers that predict clinical outcomes with NurOwn treatment. Despite this, BCLI shares fell by 4.50% in the premarket session.

Portfolio Pulse from Vandana Singh

July 07, 2023 | 12:34 pm

GLTA

Galata Acquisition Corp. and Marti Technologies Inc. have announced that their shareholders have approved the previously announced business combination. The combined company will operate as Marti Technologies, Inc. and its shares and warrants are expected to trade on the NYSE American Stock Exchange under the symbols 'MRT' and 'MRTW', respectively, switching from the symbol 'GLTA'. The business combination is expected to close on July 10, 2023.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:32 pm

SPY

The USA Nonfarm Payrolls for June came in at 209K, lower than the estimated 225K and significantly lower than the previous month's 306K.

Portfolio Pulse from Happy Mohamed

July 07, 2023 | 12:30 pm

LVMHF

LVMH Moet Hennessy Louis Vuitton SE (LVMHF) backed private equity firm is considering an IPO for Birkenstock in the US market, potentially valuing the company at over $6 billion. The IPO may occur this or next year. LVMHF reported a 17% YoY sales growth in Q1 FY23.

Portfolio Pulse from Lekha Gupta

July 07, 2023 | 12:30 pm

LEVI

Levi Strauss & Co reported a decline in Q2 margins and issued a lower than expected EPS guidance for FY23. The company also noted an 18% increase in inventories on a dollar basis, which has led to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 07, 2023 | 12:30 pm